Get all premium features to the best stock analysis tool

MetLife Names Jordan Canter Head of Federal Government Affairs and Regulatory Policy

NEW YORK--(BUSINESS WIRE)-- #MetLife--MetLife, Inc. (NYSE: MET) announced that Jordan Canter will join as head of Federal Government Affairs and Regulatory Policy, effective April 20. She will oversee MetLife's federal government affairs and global regulatory policy, collaborating with internal and external stakeholders to support the company's business priorities. Based in Washington, D.C., Canter will report to Susan Greenwell, senior vice president and head of Global Government Affairs. “As the policy.

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.002 percent of MetLife shares of common stock outstanding as of February 12, 2026. Potemkin's offer price of $51.60 per share is approximately 27.09 percent lower than the $70.77 closing price of MetLife common.

MetLife Confirms First Quarter 2026 Series A Preferred Stock Dividend

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has confirmed its previously announced declaration of the first quarter 2026 dividend of $0.31501229 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will s.

AM Best Assigns Issue Credit Rating to MetLife, Inc.'s New Subordinated Debentures

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to the newly issued $1 billion, 5.85% subordinated debentures, due March 15, 2056, issued by MetLife, Inc. (MetLife) (headquartered in New York, NY) [NYSE: MET]. The outlook assigned to this Credit Rating (rating) is stable. All other ratings of MetLife and its subsidiaries remain unchanged. The proceeds from this debt issuance are expected to be used to cover general business purposes. MetLife.